Zoono Group (ASX: ZNO) — Perfil da empresa, notícias e dados financeiros
Zoono Group is a biotechnology company that develops, manufactures, and distributes long-lasting, alcohol-free antimicrobial solutions for personal, household, and commercial applications.
Zoono Group
Zoono Group is a biotechnology company that develops, manufactures, and distributes long-lasting, alcohol-free antimicrobial solutions for personal, household, and commercial applications. The company utilizes a proprietary antimicrobial technology that physically bonds to surfaces and skin, forming a protective microscopic barrier that destroys pathogens without relying on toxic chemicals. Its product portfolio includes alcohol-free hand sanitizers, mould defence systems, body and surface wipes, foot guard sprays, and commercial surface protectants. Zoono Group serves consumer markets as well as commercial enterprises, healthcare, transportation, and industrial sectors across international markets including Australia, New Zealand, and Asia.
Resumo
Operações
Produtos e/ou serviços de Zoono Group
- Hand Sanitisers: Alcohol-free topical antimicrobial foams and sprays formulated to bond to skin, providing extended protection against bacteria and viruses across retail consumer channels and commercial workplace environments in global markets.
- Mould Defence Systems: Surface treatment sprays and room deodorisers designed to eliminate active mould spores and create a durable barrier preventing fungal recurrence on interior building surfaces and household structures.
- Body and Surface Wipes: Pre-moistened sanitising wipes engineered for single-use application on personal skin and hard surfaces, delivering rapid pathogen neutralisation and portable hygiene control for healthcare and everyday consumer use.
- Commercial and Business Hygiene: Industrial-grade bulk antimicrobial formulations, spray application systems, and workplace hygiene packs supplied to corporate facilities, public transit networks, schools, and food processing facilities across international regions.
- Foot Guard Sprays: Specialty foaming antimicrobial foot treatments formulated to eliminate odour-causing bacteria and fungal organisms, packaged in pump bottles for personal daily care, athletic facilities, and foot hygiene applications.
- Global Distribution and Licensing: B2B partnership and licensing operations managing international commercial agreements, regional distribution networks, and trial deployments across eight primary geographic markets including Australasia, Asia, and Europe.
equipe executiva do Zoono Group
- Paul Russell HyslopMD & Executive Director
- Paul RavlichChief Financial Officer
- Lewis Andrew Craig MacKinnonChief Operating Officer
- Elissa C. HansenCompany Secretary & Independent Non-Executive Director
Histórico de dividendos
Dividendos por ação pagos pela Zoono Group, por ano fiscal.
| Ano fiscal | Intermediário | Final | Especial | Total |
|---|---|---|---|---|
| FY2021 | NZ$0.0226 | — | — | NZ$0.0226 |
Principais indicadores financeiros
Resultados divulgados pela Zoono Group, em AUD.
- Cap. de mercado
- 19,7 mi
- Receita (TTM)
- 1,7 mi
- P/L
- —
- LPA (diluído, TTM)
- 0.0
- Dividend yield
- —
- Margem de lucro
- -107.0%
| Fim do ano fiscal | Receita | Resultado operacional | Lucro líquido |
|---|---|---|---|
| 1,5 mi | -1,4 mi | -1,6 mi | |
| 1,2 mi | -3,2 mi | -3,6 mi | |
| 960,3 mil | -3,7 mi | -8,3 mi | |
| 3,1 mi | -4,8 mi | -322 mil |